Welcome to Cool Blue Media's Crowdcast profile...
The past 24 months have brought Virtual Reality and Augmented Reality to the public's attention. Virtual Reality has already been in use in Surgical Robotics and has been implemented by several medical device companies and is in use in many operating rooms.
Clinicians in behavioral health have developed treatment protocols for depression, and others. Some are using it for diagnostics as well as treatment. The field is ripe for study. PubMed.com is a valuable resource for my readers.
Our source for information in today's post is Dr. Walter Greenleaf (Stanford University). sponsored by Crowdcast a live streaming application.
Virtual Reality shares the limelight now with another superstar, Artificial Intelligence. Undoubtedly the two will join forces, merge and become Virtual Intelligence or some other eponym as an eye catcher for engagement. At the least our lexicon is changing rapidly.
Walter Greenleaf is a behavioral neuroscientist and a medical technology developer working at Stanford University. With over three decades of research and development experience in the field of digital medicine and medical virtual reality technology, Walter is considered a leading authority in the field. Dr. Greenleaf has designed and developed numerous clinical systems over the last thirty-three years, including products in the fields of: surgical simulation, 3D medical visualization, telerehabilitation, clinical informatics, clinical decision support, point-of-care clinical data collection, ergonomic evaluation technology, automatic sleep-staging systems, psychophysiological assessment, and simulation-assisted rehabilitation technologies, as well as products for behavioral medicine.
As a research scientist, Dr. Greenleaf’s focus has been on age-related changes in cognition, mood, and behavior. His early research was on age-related changes in the neuroendocrine system and the effects on human behavior. He served as the Director of the Mind Division, Stanford Center on Longevity, where his focus was on age-related changes in cognition. He is currently a Distinguished Visiting Scholar at Stanford University’s MediaX Program, a Visiting Scholar at Stanford University’s Virtual Human Interaction Lab, the Director of Technology Strategyat the University of Colorado National Mental Health Innovation Center, and a member of the Board of Directors for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship.
As a medical technology developer, Dr. Greenleaf’s focus has been on computer supported clinical products, with a specific focus on virtual reality and digital health technology to treat Post-traumatic Stress Disorder (PTSD), Anxiety Disorders, Traumatic Brain Injury and Stroke, Addictions, Autism, and other difficult problems in behavioral and physical medicine.
Dr. Greenleaf founded and served as CEO for Greenleaf Medical Systems, a business incubator; InWorld Solutions, a company specializing in the therapeutic use of virtual worlds for behavioral health care; and Virtually Better, a company that develops virtual environments for the treatment of phobias, anxiety disorders, and PTSD. In addition to his research at Stanford University, Walter is SVP of Strategic & Corp. Affairs to MindMaze and Chief Science Advisor to Pear Therapeutics. He is a VR technology and neuroscience advisor to several early-stage medical product companies, and is a co-founder of Cognitive Leap.
No comments:
Post a Comment